Follow
Val Gebski
Val Gebski
NHMRC Clinical TRials Centre, University of Sydney
Verified email at ctc.usyd.edu.au
Title
Cited by
Cited by
Year
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
KF Schulz, DG Altman, D Moher
Journal of Pharmacology and pharmacotherapeutics 1 (2), 100-107, 2010
213112010
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
KM Sjoquist, BH Burmeister, BM Smithers, JR Zalcberg, RJ Simes, ...
The lancet oncology 12 (7), 681-692, 2011
19102011
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised …
E Pujade-Lauraine, JA Ledermann, F Selle, V Gebski, RT Penson, ...
The lancet oncology 18 (9), 1274-1284, 2017
16692017
Minimally invasive versus abdominal radical hysterectomy for cervical cancer
PT Ramirez, M Frumovitz, R Pareja, A Lopez, M Vieira, R Ribeiro, A Buda, ...
New England Journal of Medicine 379 (20), 1895-1904, 2018
16492018
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
V Gebski, B Burmeister, BM Smithers, K Foo, J Zalcberg, J Simes
The lancet oncology 8 (3), 226-234, 2007
14992007
Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial
ARL Stevenson, MJ Solomon, JW Lumley, P Hewett, AD Clouston, ...
Jama 314 (13), 1356-1363, 2015
11332015
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ...
The lancet oncology 6 (9), 659-668, 2005
11242005
Checkpoint inhibitors in metastatic EGFR-mutated non–small cell lung cancer—a meta-analysis
CK Lee, J Man, S Lord, M Links, V Gebski, T Mok, JCH Yang
Journal of Thoracic Oncology 12 (2), 403-407, 2017
7672017
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration
S Hopewell, M Clarke, D Moher, E Wager, P Middleton, DG Altman, ...
PLoS medicine 5 (1), e20, 2008
7482008
Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse
E Pujade-Lauraine, U Wagner, E Aavall-Lundqvist, V Gebski, M Heywood, ...
Journal of clinical oncology 28 (20), 3323-3329, 2010
7072010
Lymphomas in Eμ-Pim1 transgenic mice exposed to pulsed 900 MHz electromagnetic fields
MH Repacholi, A Basten, V Gebski, D Noonan, J Finnie, AW Harris
Radiation research 147 (5), 631-640, 1997
6811997
Improving the quality of life during chemotherapy for advanced breast cancer
A Coates, V Gebski, JF Bishop, PN Jeal, RL Woods, R Snyder, ...
New England Journal of Medicine 317 (24), 1490-1495, 1987
6481987
Randomised trial of SIR-SpheresŪ plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
B Gray, G Van Hazel, M Hope, M Burton, P Moroz, J Anderson, V Gebski
Annals of Oncology 12 (12), 1711-1720, 2001
6402001
Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial
D Sullivan, AG Olsson, R Scott, JB Kim, A Xue, V Gebski, SM Wasserman, ...
Jama 308 (23), 2497-2506, 2012
6242012
Impact of EGFR inhibitor in non–small cell lung cancer on progression-free and overall survival: a meta-analysis
CK Lee, C Brown, RJ Gralla, V Hirsh, S Thongprasert, CM Tsai, EH Tan, ...
Journal of the National Cancer Institute 105 (9), 595-605, 2013
6122013
SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma
PKH Chow, M Gandhi, SB Tan, MW Khin, A Khasbazar, J Ong, SP Choo, ...
Journal of clinical oncology 36 (19), 1913-1921, 2018
6002018
Oxygen saturation and outcomes in preterm infants
BOOST II United Kingdom, Australia, and New Zealand Collaborative Groups
New England Journal of Medicine 368 (22), 2094-2104, 2013
5122013
Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non–small cell lung carcinoma: a systematic …
CK Lee, J Man, S Lord, W Cooper, M Links, V Gebski, RS Herbst, ...
JAMA oncology 4 (2), 210-216, 2018
5072018
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III …
NC Tebbutt, K Wilson, VJ Gebski, MM Cummins, D Zannino, ...
5052010
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.
A Coates, V Gebski, D Signorini, P Murray, D McNeil, M Byrne, JF Forbes
Journal of Clinical Oncology 10 (12), 1833-1838, 1992
4371992
The system can't perform the operation now. Try again later.
Articles 1–20